Beamtree Wins A$2m Saudi Contract and Tightens Strategy Amid Cost Reset

Beamtree Holdings Ltd ( (AU:BMT) ) has provided an update.

Beamtree Holdings has secured a A$2 million, 12‑month contract with Saudi Arabia’s Fakeeh Care Group to provide coding, coding assurance and analytics services as the hospital operator adapts to major clinical coding and reimbursement reforms. The deal deepens Beamtree’s presence in Saudi Arabia, where it has already undertaken national data quality audits, implemented its PICQ tool and entered a partnership with Lean Business Services to deliver integrated coding solutions.

As part of an ongoing strategic review, the board is cutting costs so that cash operating expenses align with revenue by July 2026, aiming for cash operating profit break-even after product development in FY27. Beamtree will concentrate investment on its highest-growth product lines and has withdrawn guidance for double-digit annual recurring revenue growth in FY26, citing delayed deal closures, with further details on product and market priorities to be outlined with full-year results.

The most recent analyst rating on (AU:BMT) stock is a Buy with a A$0.30 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

More about Beamtree Holdings Ltd

Beamtree Holdings Limited is an Australian health technology company focused on data platforms, clinical coding solutions and diagnostic decision support. Its products include Health Roundtable and Evolve data platforms, a Coding Suite for clinical coding quality and risk-scoring, and RippleDown, a rule-based diagnostic decision support tool, serving hospitals across Australia, New Zealand and the U.K.

Average Trading Volume: 726,716

Technical Sentiment Signal: Sell

Current Market Cap: A$34.88M

For a thorough assessment of BMT stock, go to TipRanks’ Stock Analysis page.